Drug intelligence / Profile preview

Hyalgen

Development stage
Preclinical
Lead developer
Fidia Farmaceutici
Modality
Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

**Hyalgen** is a topical nanoparticle-based dermatology and aesthetic skin care serum developed by **Endor Nanotechnology** for professional use as an adjuvant to facial aesthetic procedures. The product is described as containing **Gold Thioethylamino Hyaluronic Acid** consisting of low molecular weight hyaluronic acid-coated gold nanoparticles, with reported particle dimensions of about 10 nm gold cores and roughly 22 nm final particles. Its proposed mechanism is targeted interaction of the hyaluronic acid-coated nanoparticles with **CD44**, with downstream stimulation of endogenous hyaluronic acid, collagen, and elastin production to improve skin firmness and reduce fine lines and wrinkles. Hyalgen appears to have been positioned as a cosmeceutical or dermatology product used topically in combination with radiofrequency and other aesthetic procedures such as HIFU, microneedling, and plasma pen treatments rather than as a conventional approved pharmaceutical therapeutic.

Brand names
Hyalgen
Other names
Gold Thioethylamino Hyaluronic AcidAuHA
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Hyalgen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyalgen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call